PHARMADANICA A/S: Financial statements 2024
CVR: 19056007
Source: annual report 2024, Danish Business Authority
01/04/2023 – 31/03/2024
PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK -15,052 compared with DKK -1,054,906 the year before. Equity in the 2024 report amounted to DKK 17,486,000. The solvency ratio was 91.8%.
- Profit/Loss
- DKK -15,052
- Equity
- DKK 17,486,000
- Total Assets
- DKK 19,038,155
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | -15K | 17.5M | - |
| 2023 | - | - | -1.1M | 17.5M | - |
| 2022 | - | - | 476K | 18.6M | - |
| 2021 | - | - | -792K | 18.1M | - |
| 2020 | - | - | -777K | 18.9M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout PHARMADANICA A/S
PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.